Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of upadacitinib in patients with severe alopecia areata, including baricitinib-refractory cases: A case series of 22 patients.

Journal of the American Academy of Dermatology·2025
Same author

Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice.

The British journal of dermatology·2021
Same author

Omalizumab in cold urticaria in children: Retrospective case series of 13 patients, review of the literature.

Annales de dermatologie et de venereologie·2021
Same author

Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Drug survival and postdrug survival of systemic treatments in a national French cohort of children with atopic dermatitis.

The British journal of dermatology·2020
Same author

The chemical acetophenone azine: an important cause of shin and foot dermatitis in children.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

[Patch-test methods: materials and allergens].

N Raison-Peyron1

  • 1UF d'allergologie, service de dermatologie, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France. n-raison@chu-montpellier.fr

Annales De Dermatologie Et De Venereologie
|August 19, 2009
PubMed
Summary
This summary is machine-generated.

This study details patch testing methods, including chamber tests and standard/additional allergen series. It provides information on allergens within the European Standard Series for accurate diagnosis.

More Related Videos

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Related Experiment Videos

Last Updated: Jun 20, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Area of Science:

  • Dermatology
  • Allergology
  • Contact Dermatitis Research

Context:

  • Patch testing is a crucial diagnostic tool for allergic contact dermatitis.
  • Standardized allergen series are essential for consistent and reliable testing.
  • Understanding various chamber test methods improves diagnostic accuracy.

Purpose:

  • To elucidate the methodologies employed in patch testing.
  • To detail the composition and application of standard and additional patch test series.
  • To provide comprehensive information on allergens included in the European Standard Series.

Summary:

  • The document outlines diverse patch testing techniques, encompassing various chamber tests.
  • It elaborates on the standard and additional series of patch tests utilized in clinical practice.
  • Specific information regarding the allergens constituting the European Standard Series is presented.

Impact:

  • Facilitates improved diagnostic accuracy for allergic contact dermatitis.
  • Supports the standardization of patch testing protocols globally.
  • Enhances clinical understanding and application of allergen identification through patch testing.